NCT07744945

Brief Summary

The goal of this observational pilot study is to learn about the ability of the PureWick® Flex Female External Catheter and the PureWIck® Male External Catheter to capture urine output in adult ICU patients compared to indwelling urinary catheters. The study will also gather feedback from ICU clinicians about the suitability of PureWick® urine output data to inform clinical decision-making.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
2mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Aug 2026Oct 2026

First Submitted

Initial submission to the registry

July 10, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

August 4, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

July 10, 2026

Last Update Submit

July 31, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urine Capture Rate

    Capture rate is calculated as the weight of captured urine (post-void graduated cylinder weight - pre-void graduated cylinder weight) / total urine volume (captured urine + leaked urine (post-void absorbent pad weight - pre-void absorbent pad weight) \* 100

    Approximately every 4 hours for up to 72 hours

Secondary Outcomes (1)

  • ICU Clinician Acceptability

    From start of the observation period to the end of the observation period, up to 72 hours

Study Arms (4)

Male Indwelling Catheter

Adult male ICU patients with an indwelling urinary catheter for urine output monitoring

Device: Indwelling Urinary Catheter

Female Indwelling Catheter

Adult female ICU patients with an indwelling urinary catheter for urine output monitoring

Device: Indwelling Urinary Catheter

Male External Catheter

Adult male ICU patients with an external urinary catheter for urine output monitoring

Device: External Urinary Catheter

Female External Catheter

Adult female ICU patients with an external urinary catheter for urine output monitoring

Device: External Urinary Catheter

Interventions

A non-sterile, external catheter intended for non-invasive urine output management

Also known as: PureWick
Female External CatheterMale External Catheter

A thin, flexible, sterile tube that is inserted through the urethra into the bladder to drain urine, typically into a urine meter

Also known as: Foley catheter
Female Indwelling CatheterMale Indwelling Catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult ICU patients requiring urine output monitoring as part of their fluid management strategy

You may qualify if:

  • Adult patients =18 years at the time of ICU admission
  • Female and Male Patients requiring urine output monitoring
  • Provision of a signed and dated informed consent form

You may not qualify if:

  • Frequent episodes of bowel incontinence without a fecal management system in place; or
  • Has moderate to heavy menstruation or vaginal bleeding and cannot use a tampon or menstrual cup; or
  • Has urinary retention; or
  • Is agitated, combative, restless, and/or uncooperative and may remove or dislodge the external catheter or indwelling catheter; or
  • Presence of moderate to severe insensible fluid loss, including but not limited to: Diaphoresis; Anasarca; or, based on the investigator's assessment, is unlikely to provide accurate urine leakage measurements on the pad due to the presence of other fluids (e.g. blood, stool); or
  • Any other condition that, in the opinion of the investigator, would preclude them from participating in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intermountain Medical Center

Murray, Utah, 84111, United States

Location

Central Study Contacts

Kirsten Hammitt

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2026

First Posted

August 4, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

August 4, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations